All News HBM Healthcare Investments AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:48 2023-12-01 am EST			5-day change	1st Jan Change
175.00 ^CHF	0.00%		+0.34%	-12.94%

Dec. 01	AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	MT
Nov. 21	Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	MT

Key Figures 30.11.2023	Dec. 01	EQ
AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	Nov. 30	MT
AbbVie to acquire HBM portfolio company ImmunoGen for USD 10.1 billion in cash	Nov. 30	EQ
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	Nov. 21	MT
Key Figures 15.11.2023	Nov. 16	EQ
Key Figures 31.10.2023	Nov. 02	EQ
Key Figures 15.10.2023	Oct. 16	EQ
HBM Healthcare Investments Launches Share Buyback	Oct. 16	MT
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Oct. 16	CI
HBM Healthcare Investments Logs Higher Fiscal H1 Loss	Oct. 16	MT
HBM Healthcare Investments activates share buyback programme	Oct. 16	EQ
HBM Healthcare Investments publishes Half-Year Report as at 30 September 2023 with key figures for the second quarter of the 2023/2024 financial year	Oct. 16	EQ
HBM Healthcare Investments : Half-Year Report September 2023	Oct. 11	PU
HBM Healthcare Investments Flags Fiscal H1 Loss	Oct. 03	MT
Key Figures 30.09.2023	Oct. 02	EQ
HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 237.22 as at 30 September 2023	Oct. 02	EQ
Key Figures 15.09.2023	Sep. 18	EQ
Key Figures 31.08.2023	Sep. 01	EQ
Key Figures 15.08.2023	Aug. 16	EQ
Key Figures 31.07.2023	Aug. 02	EQ

No results for this search